RadNet (RDNT) Liabilities and Shareholders Equity (2010 - 2026)
RadNet (RDNT) posted Liabilities and Shareholders Equity of $3.9 billion for Q1 2026, up 3.37% sequentially from $3.8 billion in Q4 2025, and up 16.46% YoY from $3.3 billion in Q1 2025.
RadNet (RDNT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
RadNet has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $3.9 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 16.46% year-over-year to $3.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 billion (up 12.92% YoY) and the FY2025 annual result came in at $3.8 billion, up 14.36% from the prior year.
- Liabilities and Shareholders Equity rose to $3.9 billion in Q1 2026 per RDNT's latest filing, from $3.8 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $3.9 billion in Q1 2026 and troughed at $2.1 billion in Q1 2022.
- A 5-year average of $3.0 billion and a median of $3.0 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity rose 23.01% in 2024, then grew 8.84% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $2.4 billion in 2022, then climbed by 10.54% to $2.7 billion in 2023, then grew by 22.16% to $3.3 billion in 2024, then advanced by 14.36% to $3.8 billion in 2025, then increased by 3.37% to $3.9 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.9 billion, $3.8 billion, and $3.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | RadNet | 5.18 Bn | 4.73 Bn | 25.12 Mn | 3.89 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.89 Bn |
| Dec 31, 2025 | 3.76 Bn |
| Sep 30, 2025 | 3.67 Bn |
| Jun 30, 2025 | 3.51 Bn |
| Mar 31, 2025 | 3.34 Bn |
| Dec 31, 2024 | 3.29 Bn |
| Sep 30, 2024 | 3.28 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 2.97 Bn |
| Dec 31, 2023 | 2.69 Bn |
| Sep 30, 2023 | 2.69 Bn |
| Jun 30, 2023 | 2.71 Bn |
| Mar 31, 2023 | 2.41 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 2.25 Bn |
| Jun 30, 2022 | 2.24 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 2.06 Bn |
| Sep 30, 2021 | 2.04 Bn |
| Jun 30, 2021 | 2.03 Bn |